Incidence of Osteoporosis in Patients with COPD According to Different Methods of Glucocorticoid Administration.

Lee, Yang Deok; Lee, Kang Hyu; Lee, Heung Bum; Lee, Yong Chul; Rhee, Yang Keun

doi:2003.54.1.15

Tuberc Respir Dis > Volume 54(1); 2003 > Article

Original Article

Tuberculosis and Respiratory Diseases 2003;54(1):15-21.
DOI: https://doi.org/10.4046/trd.2003.54.1.15 Published online January 1, 2003.

Incidence of Osteoporosis in Patients with COPD According to Different Methods of Glucocorticoid Administration.

Yang Deok Lee, Kang Hyu Lee, Heung Bum Lee, Yong Chul Lee, Yang Keun Rhee

¹Department of Internal Medicine, Chonbuk National University Medical School, Korea. lhbmd@moak.chonbuk.ac.kr
²Research Institute of Clinical Medicine, Chonbuk National University Medical School, Korea.

Abstract

BACKGROUND
There are many risk factors for osteoporosis in patients with chronic obstructive pulmonary disease(COPD). These include smoking, a low body mass index, insufficient exercise, and the use of glucocortcoids. However, there is lack of data on the incidence of osteoporosis according to the different glucocorticoid administration methods in patients with COPD. This study compared the incidence of osteoporosis according to the different administration methods of glucocorticoid. METHODS: A matched case-controlled study (gender, age, cumulative steroid dose and pack-years of smoking) was conducted. Forty-five patients with documented COPD for at least a 3 year duration and a cumulative glucocorticoid dose above 1,000 mg were enrolled in study. The patients were classified into the following three groups. First, fifteen patients received continuous inhaled glucocorticoid with intermittent oral steroids but had no admission history due to an acute exacerbation(Group I). Secondly, fifteen patients received a multiple course of oral steroids with additional inhaled glucocorticoid but had no admission history due to their acute exacerbation(Group II). Lastly, fifteen patients received intermittent oral or inhaled glucocorticoids and had an admission history due to the acute exacerbation with intravenous steroid treatment for at least 2 weeks per year(Group III). The enrolled patients had apulmonary function test and bone densitometry performed at the lumbar spine and femoral neck. RESULTS: The patients from Group III had significantly high incidence of osteoporosis in the lumbar and femoral neck compared to Group I and Group II (p<0.01). CONCLUSION: The incidence of osteoporosis in patients with COPD appears to be strongly affected by the method of steroid administration. This result suggests that intravenous steroid administration is strongly associated with the risk of osteoporosis.

Key Words: Osteoporosis, COPD, Glucocorticoid administration methods